aspirin has been researched along with resolvin d1 in 38 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (7.89) | 29.6817 |
| 2010's | 29 (76.32) | 24.3611 |
| 2020's | 6 (15.79) | 2.80 |
| Authors | Studies |
|---|---|
| Arita, M; Gotlinger, K; Hong, S; Serhan, CN | 1 |
| Campbell, E; Colgan, SP; Gotlinger, K; Oh, SF; Petasis, NA; Serhan, CN; Sun, YP; Uddin, J; Yang, R | 1 |
| Bannenberg, GL | 1 |
| Flower, RJ; Norling, LV; Perretti, M; Serhan, CN; Spite, M; Yang, R | 1 |
| Bento, AF; Calixto, JB; Claudino, RF; Dutra, RC; Marcon, R | 1 |
| Carlo, T; Croze, RH; Eickmeier, O; Gao, F; Haworth, O; Hilberath, JN; Levy, BD; Pfeffer, MA; Seki, H; Uddin, M | 1 |
| Carlo, T; Croze, R; Haworth, O; Levy, BD; Oh, SF; Pfeffer, MA; Priluck, R; Rogerio, AP; Serhan, CN; Uddin, M | 1 |
| Carozza, RB; Chiang, N; Dartt, DA; Hodges, RR; Jiao, J; Li, D; Serhan, CN; Shatos, MA | 1 |
| Carlström, M; Eriksson, LI; Gómez-Galán, M; Gustavsson, D; Harding, RE; Lindskog, M; Terrando, N; Yang, T | 1 |
| Chen, J; Fu, J; Gao, R; Hu, Y; Li, Z; Shetty, S; Wang, S; Zhang, P | 1 |
| Gao, H; Liu, Y; Petasis, NA; Serhan, CN; Tang, H; Yan, C | 1 |
| Arnardottir, HH; Colas, RA; Dalli, J; Serhan, CN; Shinohara, M | 1 |
| Arias, S; Cho, Y; Cox, R; Fukumoto, I; Fukumoto, J; Kolliputi, N; Lockey, RF; Parthasarathy, PT; Phillips, O | 1 |
| Khaddaj-Mallat, R; Morin, C; Rizcallah, E; Rousseau, É; Sirois, C; Sirois, M | 1 |
| Fortin, S; Hiram, R; Marouan, S; Morin, C; Rizcallah, E; Rousseau, E; Sirois, C; Sirois, M | 1 |
| Abdulnour, RE; Ai, X; Bai, Y; Colas, RA; Dalli, J; Douda, DN; Levy, BD; Serhan, CN; Sham, HP | 1 |
| Croasdell, A; Lacy, SH; Phipps, RP; Sime, PJ; Thatcher, TH | 1 |
| Correia, D; Levy, BD; Ogata, H; Rodrigues Junior, V; Rogério, Ade P; Silva, MV; Sousa, RC; Teixeira, MM | 1 |
| Cunha, MM; de Oliveira, JR; Favarin, DC; Levy, BD; Magalhães, ML; Okuma, CH; Rodrigues, V; Rogerio, AP; Silva, WC; Teixeira, MM; Zambalde, ÉP | 1 |
| Cao, Q; Li, W; Liu, Y; Shu, Y; Yuan, X | 1 |
| Bennett, A; Burston, J; Chapman, V; Hathway, G; Meesawatsom, P | 1 |
| Baker, OJ; Easley, JT; Maruyama, CL; Wang, CS | 1 |
| Botchwey, EA; Olingy, CE; San Emeterio, CL; Sok, MCP; Tria, MC | 1 |
| Baker, OJ; Easley, JT; Maruyama, CL; Trump, BG; Wang, CS | 1 |
| Chatterjee, A; Chen, M; Conte, MS; Mottola, G; Wu, B | 1 |
| Bhela, S; Rajasagi, NK; Rouse, BT; Varanasi, SK | 1 |
| Huang, WQ; Liu, JX; Ma, Y; Xiu, HH; Xu, KQ; Zhang, T | 1 |
| Hu, X; Liang, Y; Zhao, H; Zhao, M | 1 |
| Hu, X; Shen, H; Wang, Y; Zhang, L; Zhao, M | 1 |
| Bielenberg, DR; Gartung, A; Gilligan, MM; Huang, S; Kieran, MW; Norris, PC; Panigrahy, D; Serhan, CN; Sukhatme, VP; Sulciner, ML | 1 |
| Baker, OJ; Dean, S; Maruyama, CL; Nam, K; Trump, BG; Wang, CS | 1 |
| Dong, Y; Jiang, L; Kong, D; Midgley, AC; Shi, J; Wang, S; Zhang, L; Zhang, X | 1 |
| Baker, OJ; Yellepeddi, VK | 1 |
| Bhat, TA; Kalathil, SG; Miller, A; Sime, PJ; Thanavala, Y; Thatcher, TH | 1 |
| Almeida-Souza, F; Benjamim, CF; Calabrese, KS; Calcia, TBB; Caruso-Neves, C; Guilherme, RF; Lemos, FS; Neves, JS; Silva, CP; Silva, JBNF | 1 |
| Ke, B; Liu, M; Wang, P; Yuan, Y; Zhu, C | 1 |
| Etemad, L; Karimi, G; Roohbakhsh, A | 1 |
| Araújo-Silva, CA; Benjamim, CF; Blanco, PJ; Bulant, CA; Canetti, C; Fraga-Junior, VS; Guilherme, RF; Lemos, FS; Magalhães, NS; Moraes, JA; Nogueira, TO; Pecli, C; Scharfstein, J; Serra, R; Silva, JBNF; Svensjö, E; Waclawiack, I | 1 |
3 review(s) available for aspirin and resolvin d1
| Article | Year |
|---|---|
Resolvins, docosatrienes, and neuroprotectins, novel omega-3-derived mediators, and their aspirin-triggered endogenous epimers: an overview of their protective roles in catabasis.
Topics: Animals; Anti-Inflammatory Agents; Aspirin; Docosahexaenoic Acids; Eicosapentaenoic Acid; Fatty Acids, Omega-3; Humans; Inflammation | 2004 |
Resolvins: Current understanding and future potential in the control of inflammation.
Topics: Animals; Anti-Inflammatory Agents; Aspirin; Docosahexaenoic Acids; Eicosapentaenoic Acid; Humans; Inflammation; Lipoxins; Molecular Structure; Signal Transduction; Structure-Activity Relationship | 2009 |
Resolvin D1: A key endogenous inhibitor of neuroinflammation.
Topics: Anti-Inflammatory Agents; Aspirin; Docosahexaenoic Acids; Humans; Inflammation; Neuroinflammatory Diseases | 2022 |
35 other study(ies) available for aspirin and resolvin d1
| Article | Year |
|---|---|
Resolvin D1 and its aspirin-triggered 17R epimer. Stereochemical assignments, anti-inflammatory properties, and enzymatic inactivation.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Cell Line; Cell Migration Inhibition; Docosahexaenoic Acids; Enzyme Inhibitors; Humans; Male; Mice; Neutrophil Infiltration; Stereoisomerism | 2007 |
Cutting edge: Humanized nano-proresolving medicines mimic inflammation-resolution and enhance wound healing.
Topics: Animals; Anti-Inflammatory Agents; Aspirin; Cell Movement; Chromatography, Liquid; Docosahexaenoic Acids; Humans; Inflammation; Keratinocytes; Lipids; Lipoxins; Male; Mice; Microspheres; Molecular Mimicry; Nanoparticles; Neutrophils; Peritonitis; Tandem Mass Spectrometry; Temporomandibular Joint; Temporomandibular Joint Disorders; Wound Healing | 2011 |
Omega-3 fatty acid-derived mediators 17(R)-hydroxy docosahexaenoic acid, aspirin-triggered resolvin D1 and resolvin D2 prevent experimental colitis in mice.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Antibodies, Monoclonal; Aspirin; Bone Marrow Cells; Cell Adhesion Molecules; Colitis; Cytokines; Dextran Sulfate; Docosahexaenoic Acids; Gene Expression Regulation; Macrophages; Male; Mice; Mice, Inbred BALB C; Receptors, Formyl Peptide; RNA, Messenger; Trinitrobenzenes; Water Pollutants, Chemical | 2011 |
Aspirin-triggered resolvin D1 reduces mucosal inflammation and promotes resolution in a murine model of acute lung injury.
Topics: Acute Lung Injury; Adaptor Proteins, Signal Transducing; Airway Resistance; Animals; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Blood Platelets; Blood-Air Barrier; Disease Models, Animal; Docosahexaenoic Acids; Epinephrine; Inflammation; Inflammation Mediators; Leukocytes; Macrophages, Alveolar; Male; Mice; Neutrophils; Pulmonary Edema; Receptors, Formyl Peptide; Respiratory Mucosa; Transcription Factor RelA | 2013 |
Resolvin D1 and aspirin-triggered resolvin D1 promote resolution of allergic airways responses.
Topics: Animals; Aspirin; Asthma; Blotting, Western; Bronchoalveolar Lavage Fluid; Chemotaxis, Leukocyte; Cytokines; Disease Models, Animal; Docosahexaenoic Acids; Gene Expression Profiling; Hypersensitivity; Immunohistochemistry; Macrophages; Male; Mice; Protein Isoforms; Real-Time Polymerase Chain Reaction; Reverse Transcriptase Polymerase Chain Reaction | 2012 |
Resolvin D1 and aspirin-triggered resolvin D1 regulate histamine-stimulated conjunctival goblet cell secretion.
Topics: Animals; Aspirin; Bodily Secretions; Calcium Signaling; Cells, Cultured; Conjunctivitis, Allergic; Docosahexaenoic Acids; Extracellular Signal-Regulated MAP Kinases; Goblet Cells; Histamine; Histamine H1 Antagonists; Humans; Male; Rats; Rats, Sprague-Dawley; Receptor Cross-Talk; Receptors, G-Protein-Coupled; Receptors, Histamine H1 | 2013 |
Aspirin-triggered resolvin D1 prevents surgery-induced cognitive decline.
Topics: Animals; Aspirin; Brain; Cognition; Docosahexaenoic Acids; Electrophysiology; Immunohistochemistry; In Vitro Techniques; Locomotion; Long-Term Potentiation; Macrophages, Peritoneal; Male; Mice; Postoperative Complications; Superoxides | 2013 |
Aspirin-triggered resolvin D1 down-regulates inflammatory responses and protects against endotoxin-induced acute kidney injury.
Topics: Acute Kidney Injury; Animals; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Biomarkers; Blood Urea Nitrogen; Claudin-4; Creatinine; Cytoprotection; Disease Models, Animal; Docosahexaenoic Acids; Endotoxins; Extracellular Signal-Regulated MAP Kinases; Inflammation Mediators; Intercellular Adhesion Molecule-1; Interleukin-6; Kidney; Male; Mice; Mice, Inbred C57BL; Neutrophil Infiltration; NF-kappa B; Phosphorylation; Signal Transduction; STAT3 Transcription Factor; Time Factors; Vascular Cell Adhesion Molecule-1 | 2014 |
Protective actions of aspirin-triggered (17R) resolvin D1 and its analogue, 17R-hydroxy-19-para-fluorophenoxy-resolvin D1 methyl ester, in C5a-dependent IgG immune complex-induced inflammation and lung injury.
Topics: Acute Lung Injury; Animals; Anti-Inflammatory Agents, Non-Steroidal; Antigen-Antibody Complex; Aspirin; Bronchoalveolar Lavage Fluid; CCAAT-Enhancer-Binding Proteins; Cell Line; Chemokine CCL3; Complement C5a; Cytokines; Docosahexaenoic Acids; Immunoglobulin G; Macrophages, Alveolar; Mice; Neutrophils; NF-kappa B; Pneumonia | 2014 |
Aging delays resolution of acute inflammation in mice: reprogramming the host response with novel nano-proresolving medicines.
Topics: Aging; Animals; Aspirin; Autacoids; Docosahexaenoic Acids; Eicosapentaenoic Acid; Fatty Acids, Unsaturated; Humans; Inflammation; Inflammation Mediators; Leukocytes, Mononuclear; Macrophages; Male; Metabolomics; Mice; Mice, Inbred BALB C; Nanomedicine; Peritonitis; Principal Component Analysis; Zymosan | 2014 |
Enhanced Resolution of Hyperoxic Acute Lung Injury as a result of Aspirin Triggered Resolvin D1 Treatment.
Topics: Acute Lung Injury; Airway Resistance; Animals; Anti-Inflammatory Agents, Non-Steroidal; Apoptosis; Aspirin; Docosahexaenoic Acids; Drug Evaluation, Preclinical; Hyperoxia; Lung; Mice, Inbred C57BL; Neutrophil Infiltration; Oxidative Stress | 2015 |
Reversal of IL-13-induced inflammation and Ca(2+) sensitivity by resolvin and MAG-DHA in association with ASA in human bronchi.
Topics: Airway Resistance; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Bronchi; Bronchitis; Bronchodilator Agents; Calcium Signaling; Cyclooxygenase Inhibitors; Docosahexaenoic Acids; Drug Synergism; Fatty Acids, Omega-3; Humans; I-kappa B Kinase; In Vitro Techniques; Interleukin-13; Intracellular Signaling Peptides and Proteins; Monoglycerides; Muscle Proteins; Phosphoprotein Phosphatases; Phosphorylation; Protein Processing, Post-Translational; Receptors, G-Protein-Coupled; Transcription Factor RelA; Tumor Necrosis Factor-alpha | 2015 |
Resolvin E1 normalizes contractility, Ca2+ sensitivity and smooth muscle cell migration rate in TNF-α- and IL-6-pretreated human pulmonary arteries.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Calcium; Cell Movement; Docosahexaenoic Acids; Eicosapentaenoic Acid; Humans; Hypertension, Pulmonary; In Vitro Techniques; Indoles; Inflammation Mediators; Interleukin-6; Lipoxygenase Inhibitors; Matrix Metalloproteinase 9; Models, Biological; Monoglycerides; Myocytes, Smooth Muscle; Pulmonary Artery; Tumor Necrosis Factor-alpha; Vascular Endothelial Growth Factor A; Vasoconstriction | 2015 |
Aspirin-triggered resolvin D1 is produced during self-resolving gram-negative bacterial pneumonia and regulates host immune responses for the resolution of lung inflammation.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Bronchoalveolar Lavage Fluid; Docosahexaenoic Acids; Escherichia coli; Escherichia coli Infections; Gene Expression; Lipid Metabolism; Lipids; Lipocalin-2; Lung; Macrophages, Alveolar; Male; Mice; Mice, Inbred C57BL; Neutrophils; Phagocytosis; Pneumonia, Bacterial; Pseudomonas aeruginosa; Pseudomonas Infections | 2016 |
Resolvin D1 Dampens Pulmonary Inflammation and Promotes Clearance of Nontypeable Haemophilus influenzae.
Topics: Animals; Aspirin; Bacterial Load; Cell Movement; Cytokines; Docosahexaenoic Acids; Female; Haemophilus Infections; Haemophilus influenzae; Humans; Inflammation; Mice; Mice, Inbred C57BL; Neutrophils; Respiration | 2016 |
Effects of aspirin-triggered resolvin D1 on peripheral blood mononuclear cells from patients with Chagas' heart disease.
Topics: Adolescent; Adult; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Cell Count; Cell Proliferation; Chagas Cardiomyopathy; Docosahexaenoic Acids; Humans; Interferon-gamma; Leukocytes, Mononuclear; Middle Aged; Necrosis; Young Adult | 2016 |
The anti-inflammatory and pro-resolution effects of aspirin-triggered RvD1 (AT-RvD1) on peripheral blood mononuclear cells from patients with severe asthma.
Topics: Animals; Anti-Inflammatory Agents; Aspirin; Asthma; Cells, Cultured; Dermatophagoides pteronyssinus; Docosahexaenoic Acids; Humans; Interleukin-10; Leukocytes, Mononuclear; Mice; Neutrophils; Phagocytosis; Signal Transduction; Tumor Necrosis Factor-alpha | 2016 |
Aspirin-triggered resolvin D1 inhibits TGF-β1-induced EMT through the inhibition of the mTOR pathway by reducing the expression of PKM2 and is closely linked to oxidative stress.
Topics: A549 Cells; Aspirin; Carrier Proteins; Docosahexaenoic Acids; Epithelial-Mesenchymal Transition; Humans; Membrane Proteins; Oxidative Stress; Reactive Oxygen Species; Signal Transduction; Thyroid Hormone-Binding Proteins; Thyroid Hormones; TOR Serine-Threonine Kinases; Transforming Growth Factor beta1 | 2016 |
Inhibitory effects of aspirin-triggered resolvin D1 on spinal nociceptive processing in rat pain models.
Topics: Action Potentials; Animals; Anti-Inflammatory Agents; Aspirin; Carrageenan; Chronic Pain; Disease Models, Animal; Docosahexaenoic Acids; Enzyme Inhibitors; Gene Expression Regulation; Inflammation; Iodoacetic Acid; Male; Nerve Fibers; Osteoarthritis; Pain Threshold; Posterior Horn Cells; Rats; Rats, Sprague-Dawley; Signal Transduction; Spinal Cord | 2016 |
AT-RvD1 combined with DEX is highly effective in treating TNF-α-mediated disruption of the salivary gland epithelium.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Combined Modality Therapy; Dexamethasone; Docosahexaenoic Acids; Glucocorticoids; Inflammation; Rats; Receptors, Lipoxin; Salivary Glands; Signal Transduction; Sjogren's Syndrome; Tumor Necrosis Factor-alpha | 2016 |
Aspirin-Triggered Resolvin D1-modified materials promote the accumulation of pro-regenerative immune cell subsets and enhance vascular remodeling.
Topics: Animals; Aspirin; Biocompatible Materials; Cytokines; Docosahexaenoic Acids; Drug Delivery Systems; Immune System; Inflammation; Lactic Acid; Male; Materials Testing; Mice; Mice, Inbred C57BL; Neutrophil Infiltration; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; RAW 264.7 Cells; Regeneration; Tissue Engineering; Vascular Remodeling | 2017 |
AT-RvD1 Promotes Resolution of Inflammation in NOD/ShiLtJ mice.
Topics: Animals; Aspirin; Dexamethasone; Docosahexaenoic Acids; Epithelium; Female; Inflammation; Male; Mice; Mice, Inbred C57BL; Mice, Inbred NOD; Mice, Knockout; Salivary Glands; Sjogren's Syndrome; Xerostomia | 2017 |
Aspirin-triggered resolvin D1 attenuates PDGF-induced vascular smooth muscle cell migration via the cyclic adenosine monophosphate/protein kinase A (cAMP/PKA) pathway.
Topics: Aspirin; Blotting, Western; Cell Movement; Cells, Cultured; Cyclic AMP; Cyclic AMP-Dependent Protein Kinases; Docosahexaenoic Acids; Humans; Muscle, Smooth, Vascular; Myocytes, Smooth Muscle; Phosphorylation; Platelet-Derived Growth Factor; rac1 GTP-Binding Protein; Signal Transduction | 2017 |
Frontline Science: Aspirin-triggered resolvin D1 controls herpes simplex virus-induced corneal immunopathology.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Antiviral Agents; Aspirin; Chemokine CCL2; Chemokine CXCL2; Corneal Neovascularization; Corneal Stroma; Docosahexaenoic Acids; Female; Gene Expression Regulation; Herpes Simplex; Herpesvirus 1, Human; Humans; Interleukins; Keratitis, Herpetic; Matrix Metalloproteinase 9; Mice; Mice, Inbred BALB C; MicroRNAs; Neutrophils; Severity of Illness Index; Signal Transduction; Th1 Cells; Th17 Cells; Vascular Endothelial Growth Factor A | 2017 |
Protective effect of aspirin-triggered resolvin D1 on hepatic ischemia/reperfusion injury in rats: The role of miR-146b.
Topics: Alanine Transaminase; Animals; Anti-Inflammatory Agents; Apoptosis; Aspartate Aminotransferases; Aspirin; Docosahexaenoic Acids; Liver; Male; Mice; MicroRNAs; NF-kappa B; Rats; Rats, Sprague-Dawley; Reperfusion Injury; Signal Transduction; TNF Receptor-Associated Factor 6; Tumor Necrosis Factor-alpha | 2017 |
Effects of AT-RvD1 on paraquat-induced acute renal injury in mice.
Topics: Acute Kidney Injury; Animals; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Blood Platelets; Cytokines; Docosahexaenoic Acids; Dose-Response Relationship, Drug; Gene Expression Regulation; Herbicides; Inflammation Mediators; Male; Mice; Mice, Inbred C57BL; Neutrophils; Oxidative Stress; Paraquat | 2019 |
Aspirin-triggered resolvin D1 alleviates paraquat-induced acute lung injury in mice.
Topics: Acute Lung Injury; Animals; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Cytokines; Docosahexaenoic Acids; Herbicides; Inflammation; Inflammation Mediators; Male; Mice; Mice, Inbred C57BL; NF-kappa B; Paraquat; Pulmonary Edema | 2019 |
Aspirin-triggered proresolving mediators stimulate resolution in cancer.
Topics: Animals; Antineoplastic Agents; Aspirin; Chemokine CCL2; Chemokines; Cytokines; Disease Models, Animal; Docosahexaenoic Acids; Eicosanoids; Fatty Acids, Unsaturated; Female; Inflammation; Lipoxins; Macrophages; Metabolomics; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Microtubule-Associated Proteins; Neoplasm Metastasis; Neoplasms; Nerve Tissue Proteins; Phagocytosis; Plasminogen Inactivators; Prostaglandins | 2019 |
Aspirin Triggered Resolvin D1 reduces inflammation and restores saliva secretion in a Sjögren's syndrome mouse model.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Cytokines; Disease Models, Animal; Docosahexaenoic Acids; Drug Evaluation, Preclinical; Female; Inflammation Mediators; Lymphocyte Count; Male; Mice, Inbred NOD; Saliva; Salivation; Sjogren's Syndrome; Th17 Cells | 2019 |
Regulation of the inflammatory response by vascular grafts modified with Aspirin-Triggered Resolvin D1 promotes blood vessel regeneration.
Topics: Animals; Aorta, Abdominal; Aspirin; Blood Vessel Prosthesis; Coated Materials, Biocompatible; Docosahexaenoic Acids; Human Umbilical Vein Endothelial Cells; Humans; Inflammation; Materials Testing; Mice; Rats; Rats, Sprague-Dawley; RAW 264.7 Cells; Regeneration | 2019 |
Predictive modeling of aspirin-triggered resolvin D1 pharmacokinetics for the study of Sjögren's syndrome.
Topics: Administration, Intravenous; Animals; Aspirin; Clinical Trials as Topic; Computer Simulation; Disease Models, Animal; Docosahexaenoic Acids; Drug Dosage Calculations; Drug Evaluation, Preclinical; Humans; Mice; Models, Biological; Saliva; Salivary Glands; Sjogren's Syndrome; Tissue Distribution | 2020 |
Specialized Proresolving Mediators Overcome Immune Suppression Induced by Exposure to Secondhand Smoke.
Topics: Animals; Antibodies; Aspirin; Asthma; B-Lymphocytes; Bronchoalveolar Lavage Fluid; Cytokines; Docosahexaenoic Acids; Epithelial Cells; Female; Haemophilus Infections; Haemophilus influenzae; Immune Tolerance; Immunoglobulin A; Immunoglobulin G; Inflammation; Lipoproteins; Lung; Mice; Mice, Inbred C57BL; Pneumonia; Pulmonary Disease, Chronic Obstructive; Tobacco Smoke Pollution | 2020 |
ATRvD1 Attenuates Renal Tubulointerstitial Injury Induced by Albumin Overload in Sepsis-Surviving Mice.
Topics: Acute Kidney Injury; Albumins; Animals; Aspirin; Biomarkers; Cytokines; Disease Models, Animal; Docosahexaenoic Acids; Female; Inflammation; Kidney Function Tests; Kidney Glomerulus; Male; Mice; Mice, Inbred BALB C; Proteinuria; RNA, Messenger; Sepsis | 2021 |
The inhibiting effect of Aspirin Triggered-Resolvin D1 in non-canonical pyroptosis in rats with acute keratitis.
Topics: Animals; Anti-Inflammatory Agents; Aspirin; Caspases; Docosahexaenoic Acids; Inflammation; Keratitis; Lipopolysaccharides; Pyroptosis; Rats; Rats, Wistar | 2022 |
Pleiotropic antifibrotic actions of aspirin-triggered resolvin D1 in the lungs.
Topics: Aspirin; Bleomycin; Docosahexaenoic Acids; Humans; Lung; Pulmonary Fibrosis; Transforming Growth Factor beta | 2023 |